November 2025 - Page 7 of 8

ThursdayNov 06, 2025 9:00 am

HeartBeam Inc. (NASDAQ: BEAT) Advances Toward Commercialization of Groundbreaking ECG System

ECG data is necessary for the diagnosis of all cardiac arrhythmias in order to assess severity, implications and treatment options. HeartBeam is reporting that its 12-lead ECG synthesis software for arrhythmia assessment has been submitted to the U.S. Food and Drug Administration for 510(k) clearance. To enable smooth commercialization, the company is building the infrastructure needed to support widespread adoption. In the world of heart health, palpitations are common, with atrial fibrillation (“AF”) being one of the most typical sustained arrhythmias in adults (https://nnw.fm/JQ7mk). HeartBeam (NASDAQ: BEAT) is on the verge of transforming how AF is detected and managed with…

WednesdayNov 05, 2025 11:15 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) CEO Kimberly Ann Shares Major Company Updates and Outlines Growth on the Prospector News Podcast

This article has been disseminated on behalf of  Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. In a recent appearance on the Prospector News Podcast, Kimberly Ann shared details about the Lahontan Gold Corp. and the company’s growth She spoke about the flagship asset of the company, the Santa Fe Project, and how the company is preparing to break ground in 2027 The interview also covered what the company is doing to prepare for production, how the permitting process is going, and a variety of other topics Recently, Kimberly Ann, the CEO of Lahontan Gold (TSX.V: LG)…

WednesdayNov 05, 2025 10:30 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Closes Flow-Through Private Placement Funding in Build-up to Abitibi Belt Gold Production Operation

This article has been disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. Gold explorer and near-term producer LaFleur Minerals is building up its capital reserves to fund PEA work in preparation for extraction operations at its Swanson Gold Project in the Abitibi Gold Belt of Québec, and milling operations restart at Beacon Gold Mill by early next year The company recently closed a flow-through private placement offering for aggregate gross proceeds of more than $1.66 million to help fund exploration and PEA-related work at Swanson, and any eligible ore sorting and metallurgical…

WednesdayNov 05, 2025 9:45 am

Numa Numa Resources Inc. Seizes Opportunities in Bougainville’s Mining Sector

This article has been disseminated on behalf of Numa Numa Resources and may include paid advertisements. The Panguna Mine, being redeveloped by the company and its landowner partners, has not only massive amounts of copper and gold within its walls, but also comes with attractive infrastructure assets which can be refurbished and utilized. Numa Numa's operations in Bougainville are multifaceted, encompassing not only mining for precious metals like copper and gold but also such redeveloping key infrastructure assets like the Manetai lime quarrying and calcination project, an asset necessary for separating gold from copper in a concentrator which is also…

WednesdayNov 05, 2025 9:00 am

Silvercorp Metals Inc. (NYSE-A/TSX: SVM) Reports 23% Revenue Growth and Advances El Domo Construction

This article has been disseminated on behalf of  Silvercorp Metals Inc. (NYSE-A/TSX: SVM) and may include paid advertising. Canada-based Silvercorp Metals produces silver, gold, lead, zinc and other metals with primary mining operations in China and advancing growth projects in Ecuador Q2 Fiscal 2026 revenue rose 23% YOY to approximately $83.3 million Q2 silver equivalent (silver and gold) production of 1.84 million ounces, a 5% increase YOY Construction continues at the El Domo project in Ecuador, while Silvercorp’s investment in New Pacific Metals provides exposure to two advanced silver projects in Bolivia Precious metals producer Silvercorp Metals (NYSE American/TSX: SVM) continues…

TuesdayNov 04, 2025 2:45 pm

Beeline Holdings, Inc. (NASDAQ: BLNE), On Track To Go Cash Flow Positive

Beeline Holdings, modernizing mortgage lending by aligning technology with the digital expectations of younger generations, targeting real estate investors as well as home buyers, is filling a gap that many other industry players don’t, and is now on track to go cash positive by Q1 2026 While appearing on the latest episode of The TechMediaWire Podcast, Beeline’s CEO and Co-Founder, Nick Liuzza, talked about the company’s developments, mentioning the leadership’s confidence in its products, as evidenced by their monetary investment in the company Liuzza noted that Beeline has invested millions in the development of its product, an investment that led…

TuesdayNov 04, 2025 2:00 pm

Beeline Holdings, Inc. (NASDAQ: BLNE) Reports Record Lock Day Following Fed Rate Cut, Expands Blockchain-Based Home Equity Platform

Beeline Holdings recently announced that it locked 21 loans worth nearly $8 million on the same day the Federal Reserve announced its second consecutive 25-basis-point rate cut. The company also announced the launching of BeelineEquity, a blockchain-based fractional equity platform that gives homeowners debt-free access to their property value. Management will cover these and other accomplishments when it hosts a Q3 2025 stakeholder update call on November 10, led by CEO Nick Liuzza and CFO Chris Moe. Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform that redefines the path to homeownership, reported record performance at the end of October…

TuesdayNov 04, 2025 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Strengthens Financial Foundation to Advance Multiple Value Drivers

The financing initiatives underscore a disciplined approach to capital management at a critical stage for Soligenix. The company’s leadership has emphasized that this strengthened balance sheet allows Soligenix to focus on execution rather than financing. SNGX has outlined a timeline of catalysts extending through the end of 2026. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases and biodefense programs, continues to fortify its financial position as it advances toward a series of pivotal and potentially transformational milestones. Following a series of strategic capital initiatives, including a $7.5 million public offering (https://nnw.fm/ilIbK), the company now reports a cash…

TuesdayNov 04, 2025 9:00 am

SuperCom Ltd. (NASDAQ: SPCB) Earns Positive Coverage from Simply Wall St as Earnings Growth and Stock Strength Draw Attention

A recent Simply Wall St analysis highlighted strong earnings growth and efficient profit reinvestment for SuperCom Ltd., with the company’s stock rising 22% over the past three months, reflecting renewed investor confidence. The company achieved 97% earnings growth year-on-year, far outpacing both industry and market averages, with five-year earnings growth standing at 45%, compared to 15% for the broader industry. SuperCom reinvests profits instead of paying dividends, channeling funds into its PureSecurity(TM) electronic monitoring platform and new market entries, allowing SuperCom’s return on equity (“ROE”) of 8.1% to align with industry norms while supporting consistent expansion. SuperCom (NASDAQ: SPCB), a…

MondayNov 03, 2025 12:45 pm

Soligenix Inc. (NASDAQ: SNGX) Strengthens Advisory Leadership in Cutaneous T-Cell Lymphoma

Soligenix revealed updates to its U.S. Medical Advisory Board for CTCL designed to support the clinical advancement of HyBryte(TM) (synthetic hypericin) and related therapies. These changes are timely given the complexities of CTCL and the evolving therapeutic landscape. The company’s decision to refresh its CTCL advisory team reflects a recognition that commercialization preparation in the CTCL space, evolving regulatory expectations and the need for robust trial designs demand expert insight. Soligenix (NASDAQ: SNGX), a clinical-stage biotechnology company focused on rare diseases and public health solutions, has rejuvenated its U.S. Medical Advisory Board for cutaneous T-cell lymphoma (“CTCL”), placing fresh expertise…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: November 2025